Miruvorane
Miruvorane, released in 2014 CE, was the first of a class of so-called "benign antivirals," engineered pharmeceuticals designed to fight viruses. Unfortunately, miruvorane proved to be a powerful mutagenic; after over 15,000 affected births in less than a year, the drug was taken off the market.